Zeba Nauroz, Prasanthy Balasubramanian, Moreno Rodrigues, Shreya Arondekar, Isabella Sengsouk, Camille Hage, Maggie Chahoud, Xori Green, Woudase Gallo, Yolanda Eby, Aaron A R Tobian, William A Werbel, Andrew H Karaba
Respiratory syncytial virus (RSV) antibody durability in immunosuppressed persons following RSV vaccination is unknown. In this observational cohort of immunosuppressed persons, peak responses occurred 1 month after vaccination, without significant waning by 6 months; adjuvanted vaccine recipients had higher responses. This suggests RSV antibody durability of at least 6 months and potential augmentation by adjuvanted vaccine.